FDA cleared the Adaptive Optics Scanning Laser Ophthalmoscope (Mona IV) from Robotrak Technologies Co., Ltd. on Oct 27, 2026 under K261740, a traditional 510(k). The device falls under product code MYC, Ophthalmoscope, Laser, Scanning, regulated at 21 CFR 886.1570 as a Class 2 device. The review panel was Ophthalmic.
FDA logged the submission as received on May 27, 2026. The decision came 153 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Robotrak Technologies Co., Ltd. in the last 12 months of the tracker.